Neonc Technologies (NASDAQ:NTHI) CEO Buys $13,110.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 3,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was acquired at an average cost of $4.37 per share, for a total transaction of $13,110.00. Following the transaction, the chief executive officer owned 3,087,000 shares in the company, valued at $13,490,190. This represents a 0.10% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Neonc Technologies Trading Down 16.3%

NTHI stock opened at $4.63 on Thursday. The business has a 50-day simple moving average of $4.14 and a two-hundred day simple moving average of $5.99. Neonc Technologies Holdings, Inc. has a 52-week low of $3.01 and a 52-week high of $12.99.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Wall Street Analyst Weigh In

NTHI has been the subject of a number of analyst reports. Alliance Global Partners assumed coverage on Neonc Technologies in a research report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price target for the company. Maxim Group began coverage on shares of Neonc Technologies in a report on Monday, May 18th. They set a “buy” rating and a $20.00 price objective on the stock. BTIG Research reiterated a “buy” rating and issued a $15.00 target price on shares of Neonc Technologies in a research note on Tuesday, May 26th. Wall Street Zen downgraded shares of Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Finally, Weiss Ratings lowered shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, June 24th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $16.00.

Institutional Trading of Neonc Technologies

A number of hedge funds have recently bought and sold shares of NTHI. Royal Bank of Canada purchased a new position in Neonc Technologies in the first quarter worth $247,000. Bank of America Corp DE bought a new position in Neonc Technologies in the 2nd quarter valued at $801,000. Vanguard Group Inc. purchased a new stake in shares of Neonc Technologies during the 3rd quarter valued at $1,279,000. HighPoint Advisor Group LLC increased its position in shares of Neonc Technologies by 20.5% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock valued at $9,466,000 after purchasing an additional 194,408 shares during the last quarter. Finally, Goldman Sachs Group Inc. bought a new stake in shares of Neonc Technologies during the 4th quarter worth $124,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.